Breaking News

LabCorp to Spin-Off Clinical Development Business

Planned spin-off will result in two independent, publicly traded companies.

Author Image

By: Charlie Sternberg

Associate Editor

LabCorp, a global life sciences company, is pursuing a spin-off of its wholly owned Clinical Development business, which will result in two independent, publicly traded companies:   Labcorp: A global laboratory business comprising the Company’s routine and esoteric labs, central labs and early development research labs, all of which are leaders with deep scientific expertise, vast health data and insights, and an extensive, advanced global laboratory network. The Clinical Developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters